Key result
Diabetic nephropathy was not associated with a higher prevalence of orthostatic hypotension compared to matched nondiabetic chronic kidney disease.
Why the study?
The study investigated the presence of orthostatic hypotension in patients with diabetic nephropathy and the factors affecting it compared with nondiabetic chronic kidney disease patients.
Does diabetic nephropathy increase the prevalence of orthostatic hypotension compared to nondiabetic chronic kidney disease?
Cross-Sectional (n=206)
Does diabetic nephropathy increase the prevalence of orthostatic hypotension compared to nondiabetic chronic kidney disease?
Orthostatic hypotension is highly prevalent in chronic kidney disease patients regardless of diabetic etiology, highlighting the need for routine postural blood pressure evaluation.
Answers are grounded in this paper and cite their sources.
Does not support differential orthostatic hypotension screening by nephropathy etiology; leaves open diabetes-specific autonomic effects in CKD.
INTRODUCTION: Orthostatic hypotension (OH) affects 5-20% of the population. Our study investigates the presence of OH in diabetic nephropathy (DNP) patients and the factors affecting OH in comparison with nondiabetic chronic kidney disease (NDCKD) patients. METHOD: Patients presented to the nephrology clinic, and those who consented were included in the study. DNP was defined by kidney biopsy and/or clinical criteria. NDCKD patients of the same sex, age, and eGFR were matched to DNP patients. Demographic parameters and medications were obtained from the records. OH was determined by Mayo clinic criteria. The same researcher used an electronic device to measure blood pressure (BP). All samples were taken and analyzed the same day for biochemical and hematologic parameters and albuminuria. RESULTS: 112 (51 F, 61 M, mean age: 62.56 ± 9.35 years) DNP and 94 (40 F, 54 M, mean age: 62.23 ± 10.08 years) NDCKD patients were included. There was no significant difference between DNP and NDCKD groups in terms of OH prevalence (70.5 vs. 61.7%, p = 0.181). Male patients had significantly higher OH prevalence than female patients (74.7 vs. 60.0%, p = 0.026). There was no significant difference in change in systolic BP between the groups (24.00 [10.00-32.00] mm Hg vs. 24.00 [13.75-30.25] mm Hg, p = 0.797), but the change in diastolic BP was significantly higher in the DNP group (8.00 [2.00-13.00] mm Hg vs. 6.00 [2.00-9.00] mm Hg, p = 0.025). In the DNP group, patients with OH had significantly higher uric acid levels than those without OH (7.18 ± 1.55 vs. 6.36 ± 1.65 mg/dL, p = 0.017). And, 73.7% of patients on calcium channel blockers developed OH (p = 0.015), and OH developed in 80.6% of 36 patients on alpha-blockers (p = 0.049). CONCLUSION: OH prevalence is very high in CKD, and etiology of CKD does not have a statistically significant effect on the frequency of OH, despite a difference that could be meaningful clinically. Therefore, patients with CKD are checked for OH, with or without concurrent diabetes mellitus. Evaluation of postural BP changes should be a part of nephrology practice.
No takes yet. Share an insight, caveat, or question.
Aytaş et al. (2021) conducted a cross-sectional in Diabetic nephropathy and nondiabetic chronic kidney disease (n=206). Diabetic nephropathy vs. Nondiabetic chronic kidney disease was evaluated on Orthostatic hypotension prevalence (p=0.181). Diabetic nephropathy was not associated with a higher prevalence of orthostatic hypotension compared to matched nondiabetic chronic kidney disease.
Synapse has enriched 10 related papers. Consider them for comparative context: